[ad_1] NATICK, Mass., Dec. 8, 2025 /PRNewswire/ — Pillar Biosciences announced today an expansion of its existing laboratory access program with AstraZeneca for NGS-based kitted liquid biopsy tumor profiling to include China. This expanded collaboration […]
